RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
161 hedge funds and large institutions have $731M invested in Revance Therapeutics, Inc. in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 61 reducing their positions, and 16 closing their positions.
Holders
161
Holders Change
+5
Holders Change %
+3.21%
% of All Funds
2.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
48
Reduced
61
Closed
16
Calls
$14.1M
Puts
$12.8M
Net Calls
+$1.27M
Net Calls Change
-$16.3M
Top Buyers
| 1 |
1
Capital World Investors
Los Angeles,
California
|
$63.4M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$7.91M |
| 3 |
3
BlackRock
New York
|
$78.6M |
| 4 |
4
Millennium Management
New York
|
$6.5M |
| 5 |
5
BAMCO Inc
New York
|
$23.3M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
T
176
TCWP
Beachwood,
Ohio
| – | – | -39 | Closed |
|
|
C
177
Covestor
London,
United Kingdom
| $0 | 13 | -12 | -48% |
|
|
AC
178
Antara Capital
New York
| – | – | – | – |
|
179
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|
|
SM
180
SG3 Management
Dorado,
Puerto Rico
| – | – | – | – |
|
181
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
182
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
HT
183
HAP Trading
New York
| – | – | – | – |
|